Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes
Provided By GlobeNewswire
Last update: Jan 10, 2025
Esther Rajavelu Appointed Interim President and Chief Executive Officer, Frank Thomas Appointed Chairman of the Board
Interim Changes to Leadership Follow the Company’s Response to a Wells Notice from the SEC Relating to Certain Public Disclosures Made in 2022
Read more at globenewswire.com
